Eikon Therapeutics appoints Ching-Pin Chang as EV P and CSO
Eikon Therapeutics announced the appointment of Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Eikon Therapeutics appoints Ching-Pin Chang as EVP and CSO
Eikon Therapeutics appointed Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.